PARADIGM BIOCAPITAL ADVISORS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | AMLX | 1.90M | $25.82M |
 | DYN | 1.90M | $24.02M |
 | PHVS | 1.84M | $45.80M |
 | ALKS | 1.72M | $51.58M |
 | ABVX | 1.56M | $132.80M |
 | APGE | 1.52M | $60.46M |
 | SYRE | 1.47M | $24.59M |
 | LENZ | 1.07M | $50.00M |
 | CDTX | 961K | $92.04M |
 | BBIO | 684K | $35.54M |
 | GPCR | 373K | $10.44M |
 | IRON | 248K | $16.37M |
Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
1.90M
Value
$25.82M
Dyne Therapeutics, Inc.
DYN
Shares Held
1.90M
Value
$24.02M
Pharvaris N.V.
PHVS
Shares Held
1.84M
Value
$45.80M
Alkermes plc
ALKS
Shares Held
1.72M
Value
$51.58M
Abivax S.A.
ABVX
Shares Held
1.56M
Value
$132.80M
Apogee Therapeutics, Inc.
APGE
Shares Held
1.52M
Value
$60.46M
Spyre Therapeutics, Inc.
SYRE
Shares Held
1.47M
Value
$24.59M
LENZ Therapeutics, Inc.
LENZ
Shares Held
1.07M
Value
$50.00M
Cidara Therapeutics, Inc.
CDTX
Shares Held
961K
Value
$92.04M
BridgeBio Pharma, Inc.
BBIO
Shares Held
684K
Value
$35.54M
Structure Therapeutics Inc.
GPCR
Shares Held
373K
Value
$10.44M
Disc Medicine, Inc.
IRON
Shares Held
248K
Value
$16.37M